Key points are not available for this paper at this time.
The epidermal growth factor receptor (EGFR; also known as ErbB1) is one of four related receptor tyrosine kinases. These receptors (EGFR, ErbB2, ErbB3 and ErbB4) are frequently overexpressed in cancer and such overexpression is associated with poor clinical outcome. Understanding the mechanisms involved in growth-factor-receptor downregulation is medically important, as several drugs that interfere with the function and trafficking of ErbB proteins are currently being developed or are already in clinical trials. EGFR has become a model protein for understanding the biology and endocytosis of related growth-factor receptors, and the mechanisms involved in its endocytosis and degradation have been scrutinized for several decades. Nevertheless, the details and principles of these processes are still poorly understood and often controversial. In particular, the literature describing how the ubiquitylation and recruitment of EGFR to clathrin-coated pits are connected is inconsistent and confusing. In this Opinion article, we discuss the impact of signaling motifs, kinase activity and ubiquitylation on clathrin-dependent endocytosis and lysosomal sorting of EGFR. In addition, we discuss potential explanations for contradicting reports, and propose models for the recruitment of ligand-activated EGFR to clathrin-coated pits as well as for lysosomal sorting of ligand-activated EGFR.
Building similarity graph...
Analyzing shared references across papers
Loading...
Inger Helene Madshus
Oslo University Hospital
Espen Stang
Oslo University Hospital
Journal of Cell Science
University of Oslo
Oslo University Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Madshus et al. (Wed,) studied this question.
synapsesocial.com/papers/69d80cb6e72b319804d17c89 — DOI: https://doi.org/10.1242/jcs.050260